Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Amitiza® (lubiprostone) – New warning
October 11, 2016 – The FDA approved a new update to the Warnings and Precautions section of the Amitiza (lubiprostone) drug label regarding syncope and hypotension.